Pharmaceutical Industry

Page 25 of 100

AC Immune shares surge on Alzheimer’s drug trial results
Health

AC Immune shares surge on Alzheimer’s drug trial results

By Naomi Kresge, James Paton and Bloomberg
August 31, 2021
The mystery drugs President Biden didn’t name during his speech on prescription meds
Politics

The mystery drugs President Biden didn’t name during his speech on prescription meds

By
August 18, 2021
A woman in Bangladesh receiving a COVID-19 vaccine
Health

On the hunt for a ‘universal’ COVID-19 vaccine as Delta variant surges

By
August 18, 2021
The politics behind President Biden’s plan to lower prescription drug prices
Politics

The politics behind President Biden’s plan to lower prescription drug prices

By
August 14, 2021
Pharmacies face extra audit burdens that threaten their existence
Health

Pharmacies face extra audit burdens that threaten their existence

By Markian Hawryluk and Kaiser Health News
August 6, 2021
Eli Lilly’s shares rises to highest since June as Alzheimer’s treatment nears final-stage trial
Finance

Eli Lilly’s shares rises to highest since June as Alzheimer’s treatment nears final-stage trial

By Robert Langreth and Bloomberg
August 3, 2021
Image of a predicted protein structure rom the malaria parasite
Health

In giant leap for biology, DeepMind’s A.I. reveals secret building blocks of human life

By
July 22, 2021
A picture of a protein shape.
Tech

DeepMind unveils how it solved a 50-year-old scientific challenge that could speed drug discovery

By
July 15, 2021
Biogen aduhelm aducanumab Alzheimer's doctor disapproval
Newsletters

The never ending Biogen Alzheimer’s drug saga delivers yet another twist

By
July 8, 2021
Biogen aduhelm aducanumab Alzheimer's doctor disapproval
Health

Biogen makes a drastic move, as doctors refuse to prescribe its controversial Alzheimer’s drug

By
July 8, 2021
Cures for many rare diseases might already exist. Why aren’t we using them?
Commentary

Cures for many rare diseases might already exist. Why aren’t we using them?

By
July 5, 2021
Glaxo reaches $2.2 billion deal with Alector to develop drug targeting Alzheimer’s, Parkinson’s
Health

Glaxo reaches $2.2 billion deal with Alector to develop drug targeting Alzheimer’s, Parkinson’s

By Suzi Ring and Bloomberg
July 2, 2021
States step up push to regulate pharmacy drug brokers
Health

States step up push to regulate pharmacy drug brokers

By Katheryn Houghton and Kaiser Health News
June 30, 2021
Want cheaper insulin? Try Walmart

Want cheaper insulin? Try Walmart

By
June 29, 2021
Intellia CRISPR gene editing stock science
Health

We can now edit genes inside the body. That sent this biotech’s stock soaring

By
June 29, 2021

Most Popular